Antagonistic Potentiality of Actinomycete- Derived Extract with Anti-Biofilm, Antioxidant, and Cytotoxic Capabilities as a Natural Combating Strategy for Multidrug-Resistant ESKAPE Pathogens
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The global increase in multidrug-resistant (MDR) bacteria has inspired researchers to develop new strategies to overcome this problem. In this study, 23 morphologically different, soil-isolated actinomycete cultures were screened for their antibacterial ability against MDR isolates of ESKAPE pathogens. Among them, isolate BOGE18 exhibited a broad antibacterial spectrum, so it was selected and identified based on cultural, morphological, physiological, and biochemical characteristics. Chemotaxonomic analysis was also performed together with nucleotide sequencing of the 16S rRNA gene, which showed this strain to have identity with Streptomyces lienomycini. The ethyl acetate extract of the cell-free filtrate (CFF) of strain BOGE18 was evaluated for its antibacterial spectrum, and the minimum inhibitory concentration (MIC) ranged from 62.5 to 250 μg/ml. The recorded results from the in vitro anti-biofilm microtiter assay and confocal laser scanning microscopy (CLSM) of sub-MIC concentrations revealed a significant reduction in biofilm formation in a concentration-dependent manner. The extract also displayed significant scavenging activity, reaching 91.61 ± 4.1% and 85.06 ± 3.14% of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), respectively. A promising cytotoxic ability against breast (MCF-7) and hepatocellular (HePG2) cancer cell lines was obtained from the extract with IC50 values of 47.15 ± 13.10 and 122.69 ± 9.12 μg/ml, respectively. Moreover, based on gas chromatography-mass spectrometry (GC-MS) analysis, nine known compounds were detected in the BOGE18 extract, suggesting their contribution to the multitude of biological activities recorded in this study. Overall, Streptomyces lienomycini BOGE18-derived extract is a good candidate for use in a natural combating strategy to prevent bacterial infection, especially by MDR pathogens.
Abstract
The global increase in multidrug-resistant (MDR) bacteria has inspired researchers to develop new strategies to overcome this problem. In this study, 23 morphologically different, soil-isolated actinomycete cultures were screened for their antibacterial ability against MDR isolates of ESKAPE pathogens. Among them, isolate BOGE18 exhibited a broad antibacterial spectrum, so it was selected and identified based on cultural, morphological, physiological, and biochemical characteristics. Chemotaxonomic analysis was also performed together with nucleotide sequencing of the 16S rRNA gene, which showed this strain to have identity with Streptomyces lienomycini. The ethyl acetate extract of the cell-free filtrate (CFF) of strain BOGE18 was evaluated for its antibacterial spectrum, and the minimum inhibitory concentration (MIC) ranged from 62.5 to 250 μg/ml. The recorded results from the in vitro anti-biofilm microtiter assay and confocal laser scanning microscopy (CLSM) of sub-MIC concentrations revealed a significant reduction in biofilm formation in a concentration-dependent manner. The extract also displayed significant scavenging activity, reaching 91.61 ± 4.1% and 85.06 ± 3.14% of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), respectively. A promising cytotoxic ability against breast (MCF-7) and hepatocellular (HePG2) cancer cell lines was obtained from the extract with IC50 values of 47.15 ± 13.10 and 122.69 ± 9.12 μg/ml, respectively. Moreover, based on gas chromatography-mass spectrometry (GC-MS) analysis, nine known compounds were detected in the BOGE18 extract, suggesting their contribution to the multitude of biological activities recorded in this study. Overall, Streptomyces lienomycini BOGE18-derived extract is a good candidate for use in a natural combating strategy to prevent bacterial infection, especially by MDR pathogens.
참고문헌 (87)
- Vivas R, "Multidrug-resistant bacteria and alternative methods to control them: an overview", Microb. Drug Resist, 25, pp.890~908 (2019)
- Boucher HW, "Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America mechanisms of antimicrobial resistance in ESKAPE pathogens", Clin. Infect. Dis, 48, pp.1~12 (2009)
- Tacconelli E, "Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis", Lancet Infect. Dis, 18, pp.318~327 (2018)
- Levin-Reisman I, "Antibiotic tolerance facilitates the evolution of resistance", Science, 355, pp.826~830 (2017)
- Santajit S, "Mechanisms of antimicrobial resistance in ESKAPE pathogens", Biomed Res. Int, 2016, pp.2475067~ (2016)
- Danquah CA, "Antimicrobial compounds from microorganisms", Antibiotics, 11, pp.285~ (2022)
- Demain AL, "Microbial drug discovery: 80 years of progress", J. Antibiot. (Tokyo), 62, pp.5~16 (2009)
- Chuah LO, "Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells", BMC Complement. Altern. Med, 19, pp.114~ (2019)
- Blazheva D, "Antioxidant potential of probiotics and postbiotics: a biotechnological approach to improving their stability", Russ. J. Genet, 58, pp.1036~1050 (2022)
- Jakubiec-Krzesniak K, "Secondary metabolites of actinomycetes and their antibacterial, antifungal and antiviral properties", Polish J. Microbiol, 67, pp.259~272 (2018)
- Fernandes CJ, "Isolation and identification of pigment producing actinomycete Saccharomonospora azurea SJCJABS01", Biomed. Pharmacol. J, 14, pp.2261~2269 (2021)
- de Castro I, "Antibiotics from haloarchaea: what can we learn from comparative genomics?", Mar. Biotechnol, 22, pp.308~316 (2020)
- Barka EA, "Taxonomy, physiology, and natural products of actinobacteria", Microbiol. Mol. Biol. Rev, 80, pp.1~43 (2016)
- Del Carratore F, "Biotechnological application of Streptomyces for the production of clinical drugs and other bioactive molecules", Curr. Opin. Biotechnol, 77, pp.102762~ (2022)
- Kemung HM, "Streptomyces sp. strain MUSC 125 from mangrove soil in Malaysia with anti-MRSA, anti-biofilm and antioxidant activities", Molecules, 25, pp.3545~ (2020)
- Pusparajah P, "Streptomyces sp.—a treasure trove of weapons to combat methicillin-resistant Staphylococcus aureus biofilm associated with biomedical devices", Int. J. Mol. Sci, 22, pp.9360~ (2021)
- Paudel B, "Maculosin, a non-toxic antioxidant compound isolated from Streptomyces sp. KTM18", Pharm. Biol, 59, pp.933~936 (2021)
- Subramanian D, "Isolation, characterization, antioxidant, antimicrobial and cytotoxic effect of marine actinomycete, Streptomyces carpaticus MK-01, against fish pathogens", Braz. Arch. Biol. Technol, 60, pp.e17160539~ (2017)
- Braña AF, "Lobophorin K, a new natural product with cytotoxic activity produced by Streptomyces sp. M-207 associated with the deep-sea coral Lophelia pertusa", Mar. Drugs, 15, pp.144~ (2017)
- Ser HL, "Streptomyces malaysiense sp. nov.: a novel Malaysian mangrove soil actinobacterium with antioxidative activity and cytotoxic potential against human cancer cell lines", Sci. Rep, 6, pp.24247~ (2016)
- Barry J, "Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals", J. Antimicrob. Chemother, 51, pp.1191~1202 (2003)
- Pérez-Vázquez M, "Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates", Int. J. Antimicrob. Agents, 17, pp.371~376 (2001)
- Sineva O, "Selective isolation of rare actinomycetes from soil", Antibiot. Chemother, 60, pp.27~33 (2015)
- Valgas C, "Screening methods to determine antibacterial activity of natural products", Braz. J. Microbiol, 38, pp.369~380 (2007)
- NCCLS, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Sixth Edition", Document M7-A6, 60~ (2003)
- Shirling EB, "Methods for characterization of Streptomyces species", Int. J. Syst. Bacteriol, 16, pp.313~340 (1966)
- Tresner HD, "Electron microscopy of Streptomyces spore morphology and its role in species differentiation", J. Bacteriol, 81, pp.70~80 (1961)
- Williams ST, "Bergey’s Manual of Systematic Bacteriology Vol. 4", pp.2452~2492 (1989), Williams & Wilkins
- Becker B, "Rapid differentiation between Nocardia and Streptomyces by paper chromatography of whole-cell hydrolysates", Appl. Microbiol, 12, pp.421~423 (1964)
- Lechevalier MP, "Chemical composition as a criterion in the classification of aerobic actinomycetes", Int. J. Syst. Bacteriol, 20, pp.435~443 (1970)
- Williams ST, "Numerical classification of Streptomyces and related genera", J. Gen. Microbiol, 129, pp.1743~1813 (1983)
- Miller DN, "Evaluation and optimization of DNA extraction and purification procedures for soil and sediment samples", Appl. Environ. Microbiol, 65, pp.4715~4724 (1999)
- Lane DJ, "Nucleic Acid Techniques in Bacterial Systematics", pp.115~175 (1991), John Wiley & Sons
- Sanger F, "DNA sequencing with chain-terminating inhibitors", Proc. Natl. Acad. Sci. USA, 74, pp.5463~5467 (1977)
- Tamura K, "MEGA11: molecular evolutionary genetics analysis version 11", Mol. Biol. Evol, 38, pp.3022~3027 (2021)
- Supaphon P, "Antimicrobial potential of endophytic fungi derived from three seagrass species: Cymodocea serrulata, Halophila ovalis and Thalassia hemprichii", PLoS One, 8, pp.e72520~ (2013)
- Castilho AL, "Detection of drug susceptibility in rapidly growing mycobacteria by resazurin broth microdilution assay", J. Microbiol. Methods, 111, pp.119~121 (2015)
- Kalishwaralal K, "Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis", Colloids Surfaces B Biointerfaces, 79, pp.340~344 (2010)
- Singh VK, "Anti-quorum sensing and anti-biofilm activity of Delftia tsuruhatensis extract by attenuating the quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa", Front. Cell. Infect. Microbiol, 7, pp.337~ (2017)
- Attimarad SL, "Screening, isolation and purification of antibacterial agents from marine actinomycetes", Int. Curr. Pharm. J, 1, pp.394~402 (2012)
- Siddhuraju P, "The antioxidant activity and free radical-scavenging capacity of dietary phenolic extracts from horse gram (Macrotyloma uniflorum (Lam.) Verdc.) seeds", Food Chem, 105, pp.950~958 (2007)
- van de Loosdrecht AA, "A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia", J. Immunol. Methods, 174, pp.311~320 (1994)
- Zothanpuia, "Production of potent antimicrobial compounds from Streptomyces cyaneofuscatus associated with fresh water sediment", Front. Microbiol, 8, pp.68~ (2017)
- Halim MMA, "Prevalence of multidrug drug resistant organisms and hand hygiene compliance in surgical NICU in Cairo University Specialized Pediatric Hospital", Egypt. Pediatr. Assoc. Gaz, 66, pp.103~111 (2018)
- Khalifa HO, "High prevalence of antimicrobial resistance in Gram-negative bacteria isolated from clinical settings in Egypt: recalling for judicious use of conventional antimicrobials in developing nations", Microb. Drug Resist, 25, pp.371~385 (2019)
- Debnath J, "Bacteriological profile and antibiotic susceptibility pattern of neonatal septicemia in a tertiary care hospital of Tripura", Indian J. Microbiol. Res, 2, pp.238~ (2015)
- Magiorakos AP, "Multidrug-resistant, extensively drugresistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance", Clin. Microbiol. Infect, 18, pp.268~281 (2012)
- Decarli A, "The impact of VITEK 2implementation for identification and susceptibility testing of microbial isolates in a Brazilian public hospital", J. Med. Microbiol, 71, pp.1543~ (2022)
- Rice LB, "Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE", J. Infect. Dis, 197, pp.1079~1081 (2008)
- Tan HK, "Cytotoxic effect of proteinaceous postbiotic metabolites produced by Lactobacillus plantarum I-UL4 cultivated in different media composition on MCF-7 breast cancer cell", Malays. J. Microbiol, 11, pp.207~214 (2015)
- Bérdy J, "Bioactive microbial metabolites: a personal view", J. Antibiot. (Tokyo), 58, pp.1~26 (2005)
- Tanaka Y, "Metabolism and products of actinomycetes. An introduction", Actinomycetologica, 4, pp.13~14 (1990)
- Al-Ansari M, "Antimicrobial potential of Streptomyces sp. to the Gram positive and Gram negative pathogens", J. Infect. Public Health, 12, pp.861~866 (2019)
- Singh LS, "Production of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India", BMC Microbiol, 14, pp.278~ (2014)
- Abdel-Haliem MEF, "Efficiency of antibiotics and gamma irradiation in eliminating Streptomyces strains isolated from paintings of ancient Egyptian tombs", J. Cult. Herit, 14, pp.45~50 (2013)
- Wilson ZE, "Molecules derived from the extremes of life", Nat. Prod. Rep, 26, pp.44~71 (2009)
- Terra L, "A novel alkaliphilic Streptomyces inhibits ESKAPE pathogens", Front. Microbiol, 9, pp.2458~ (2018)
- Holt J, "Bergey’s Manual of Determinative Bacteriology", pp.1710~1728 (1994), Williams &Wilkins
- Goodfellow M, "Bergey's Manual of Systematic Bacteriology, Volume 5: The Actinobacteria, part A", pp.1446~1804 (2012), Springer
- Lim SS, "Isolation of actinomycetes with antibacterial activity against multi-drug resistant bacteria", Malays. J. Microbiol, 14, pp.293~305 (2018)
- Sharma M, "Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus", BMC Microbiol, 19, pp.44~ (2019)
- Singhania M, "Anti-bacterial and anti-oxidant property of Streptomyces laurentii VITMPS isolated from marine soil", Curr. Bioact. Compd, 13, pp.78~81 (2017)
- Khieu TN, "Characterization and evaluation of antimicrobial and cytotoxic effects of Streptomyces sp. HUST012 isolated from medicinal plant Dracaena cochinchinensis Lour", Front. Microbiol, 6, pp.574~ (2015)
- Enright MC, "The evolution of a resistant pathogen - The case of MRSA", Curr. Opin. Pharmacol, 3, pp.474~479 (2003)
- Marinho PR, "Antibacterial activity and cytotoxicity analysis of halistanol trisulphate from marine sponge Petromica citrina", J. Antimicrob. Chemother, 67, pp.2396~2400 (2012)
- Patel R, "Biofilms and antimicrobial resistance", Clin. Orthop. Relat. Res, 437, pp.41~47 (2005)
- Park SR, "Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway", Nat. Commun, 77, pp.10710~ (2016)
- Balasubramanian S, "Marine sponge-derived Streptomyces sp. SBT343 extract inhibits staphylococcal biofilm formation", Front. Microbiol, 8, pp.236~ (2017)
- You JL, "Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66", Appl. Microbiol. Biotechnol, 76, pp.1137~1144 (2007)
- Apak R, "Antioxidant activity", capacity measurement. 2. hydrogen atom transfer (HAT)-based, mixed-mode (electron transfer (ET), J. Agric. Food Chem, pp.2016, 64[DOI]
- Jemimah Naine S, "Antimicrobial, antioxidant and cytotoxic activity of marine Streptomyces parvulus VITJS11 crude extract", Brazilian Arch. Biol. Technol, 58, pp.198~207 (2015)
- Polapally R, "Melanin pigment of Streptomyces puniceus RHPR9 exhibits antibacterial, antioxidant and anticancer activities", PLoS One, 17, pp.e0266676~ (2022)
- Tan LTH, "Antioxidative potential of a Streptomyces sp. MUM292 isolated from mangrove soil", Biomed Res. Int, 2018, pp.4823126~ (2018)
- Osama N, "Anti-cancer and antimicrobial potential of five soil Streptomycetes: a metabolomics-based study", R. Soc. Open Sci, 9, pp.211509~ (2022)
- Ortiz-López FJ, "New 3-hydroxyquinaldic acid derivatives from cultures of the marine derived actinomycete Streptomyces cyaneofuscatus M-157", Mar. Drugs, 16, pp.371~ (2018)
- Huang H, "Cytotoxic angucycline class glycosides from the deep sea actinomycete Streptomyces lusitanus SCSIO LR32", J. Nat. Prod, 75, pp.202~208 (2012)
- Łukasiewicz S, "Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-An updated review", Cancers, 13, pp.4287~ (2021)
- Ser HL, "Evaluation of antioxidative and cytotoxic activities of Streptomyces pluripotens MUSC 137 isolated from mangrove soil in Malaysia", Front. Microbiol, 6, pp.1398~ (2015)
- Fernández A, "Synergizing immunotherapy with molecular-targeted anticancer treatment", Drug Discov. Today, 19, pp.1427~1432 (2014)
- Mohamed H, "Antibacterial and cytotoxic potency of thermophilic Streptomyces werraensis MI-S.24-3 isolated from an Egyptian extreme environment", Arch. Microbiol, 203, pp.4961~4972 (2021)
- Mothana AA, "Streptomyces sp. 1S1 isolated from Southern coast of the Red Sea as a renewable natural resource of several bioactive compounds", Saudi Pharm. J, 30, pp.162~171 (2022)
- Chen J, "The biocontrol and plant growth-promoting properties of Streptomyces alfalfae XN-04 revealed by functional and genomic analysis", Front. Microbiol, 12, pp.745766~ (2021)
- El-Naggar NEA, "In vitro activity, extraction, separation and structure elucidation of antibiotic produced by Streptomyces anulatus NEAE-94 active against multidrug-resistant Staphylococcus aureus", Biotechnol. Biotechnol. Equip, 31, pp.418~430 (2017)
- Tamilmani E, "13-Docosenamide release by bacteria in response to glucose during growth—fluorescein quenching and clinical application", Appl. Microbiol. Biotechnol, 102, pp.6673~6685 (2018)
- Abdel-Motleb A, "Chemical characterization, antimicrobial, antioxidant and larvicidal activities of certain fungal extracts", J. Adv. Biotechnol. Exp. Ther, 5, pp.456~472 (2022)
- Dong L, "Lauric acid in crown daisy root exudate potently regulates root-knot nematode chemotaxis and disrupts Mi-flp-18 expression to block infection", J. Exp. Bot, 65, pp.131~141 (2014)
- Qi D, "Taxonomy and broad-spectrum antifungal activity of Streptomyces sp. SCA34 isolated from rhizosphere soil of opuntia stricta", Front. Microbiol, 10, pp.1390~ (2019)
